Corporate
News release
TopTOKYO, JAPAN – April 22, 2025 – Terumo Corporation (TSE: 4543) today announced the establishment of the “Terumo Group Statement on Nature,” a group-wide guideline for actions on the conservation and restoration of natural environments.
Terumo operates by utilizing natural resources, including water, while impacting the natural environment, such as biodiversity and ecosystems, through its business activities. The company believes reducing its environmental impact and promoting conservation and restoration of natural environments are parts of its corporate responsibility. Therefore, Terumo has positioned “Reducing the Environmental Impact” as one of its sustainability priorities and is actively working towards its realization.
The “Terumo Group Statement on Nature” specifies actions aimed at accelerating efforts for the conservation and restoration of natural environments. Based on this guideline, Terumo will assess its dependence on nature and the environmental impact within its business activities and value chain, as well as the associated risks and opportunities. In light of the assessment, Terumo will identify key environmental aspects and promote actions to address these challenges.
To promote resource usage and conservation activities that are considerate of nature, Terumo will implement the following initiatives:
Prevention of pollution through company-wide environmental management activities
Consideration of nature impacts when establishing or changing facilities at operation sites
Reduction of the negative environmental impacts across the value chain through the Human × Eco Development Guidelines*
Implementation of Nature Positive Initiatives, including nature conservation and restoration in partnership with local communities
Promotion of sustainable raw material usage that is considerate of environmental impacts
In addition, Terumo has revised the “Terumo Group EHS Policy” prior to the establishment of the statement. This revision reflects the company’s approach and direction towards global environmental issues, such as climate change, resource and material circularity, and conservation of nature.
For more details on the “Terumo Group Statement on Nature” and the “Terumo Group EHS Policy,” please refer to the following links.
Terumo Group Statement on Nature
Terumo Group EHS Policy
Terumo will continue to actively address global environmental issues in collaboration with stakeholders, to realize a sustainable society and strengthen the resilience of its entire value chain.
* Terumo’s guidelines for developing products that are friendly to both people and the environment
(Reference) Terumo Mt. Fuji Reforestation Project
Terumo has two factories in the city of Fujinomiya in Shizuoka, Japan. Both take in groundwater from springs at the foot of Mt. Fuji for use in the production of medical devices, pharmaceuticals, and other products. Recognizing that its business depends on the use of natural resources, Terumo launched the Terumo Mt. Fuji Reforestation Project in fiscal 2003 with the aim of restoring the natural forests in this area. This project involves the reforestation of parts of Mt. Fuji’s forests where many trees have been destroyed by typhoons. Repopulating these areas with native tree species will help them become more resistant to future natural disasters and ensure that they can continue to serve as a source of groundwater.
About Terumo
Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.